2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Efficacy and Safety of Three Different Treatment Regimen in De Novo Renal Transplant Patients: Month 48 Follow-Up Results of the HERAKLES Trial

C. Sommerer,¹ K. Budde,¹ V. Kliem,¹ O. Witzke,¹ M. Guba,¹ J. Jacobi,¹ B. Vogt,³ I. Hauser,¹ P. Reinke,¹ R. Stahl,¹ T. Rath,¹ M. Porstner,² D. Baeumer,² M. Zeier,¹ W. Arns,¹ F. Lehner.¹
Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients

R. El Ramahi,² S. Habib,¹ S. Rosen,³ S. Farran,³ C. Walker,³ J. Shubeilat,⁴ S. Yost,⁵ O. McCotter,⁶ M. Cassal,⁶ A. Rana,⁷ T. Boyer,¹ T. Zangeneh.²
Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers

S. Narumi,¹ Y. Watarai,¹ N. Goto,¹ T. Hiramitsu,¹ T. Yamamoto,¹ M. Tsujita,¹ M. Okada,¹ K. Futamura,¹ A. Takeda,² T. Kobayashi.³
Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

A. Weick,¹ K. George,¹ S.-M. Jafri,² D. Moonka.²
Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial

S. Bunnapradist,¹ J. Denny,² M. Waybill,³ P. West-Thielke,⁴ S. Steinberg.⁵
Efforts to Improve Living Kidney Donor Follow-Up Reporting Have Been Successful

J. Wainright,¹ M. Dew,² C. Lougee,¹ S. Taranto,¹ L. Bolton,¹ C. Thomas.³
Elderly ESRD Patients Have a Significantly Narrowed T-Cell Receptor Repertoire Diversity

L. Huang,¹ A. Langerak,² I. Wolvers - Tettero,² R. Meijers,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹
Elderly Transplant Recipients Have Improved Graft Survival

S. Reule,¹ R. Foley,¹ A. Matas,² H. Ibrahim.¹
Elective Allograft Nephrectomy After Transplant Failure

J. Augustine, K. Woodside, K. Noon, D. Hricik, E. Sanchez, J. Schulak.
Electronic Health Service to Improve Therapeutic Drug Monitoring of Immunosuppressants

M. Barten,¹ J. Garbade,² I. Hausladen,² F. Mohr.²

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z